ArticleActa neurologica Belgica2026
Atypical neuroleptic malignant syndrome without hyperthermia or rigidity in the ıntensive care unit: a diagnostic challenge.
Article in Acta neurologica Belgica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Neuroleptic malignant syndrome (NMS) is a potentially life-threatening condition associated with dopamine antagonist medications. Although the classical presentation includes hyperthermia, generalized rigidity, autonomic instability, and altered mental status, atypical forms lacking these features may occur and complicate diagnosis. We report a case most consistent with atypical NMS in a 76-year-old patient who developed acute delirium and intermittent paratonia without fever or sustained rigidity following antipsychotic exposure. The clinical course was characterized by marked autonomic instability and a transient elevation of creatine kinase, peaking early and subsequently normalizing. A temporal relationship between antipsychotic exposure, symptom onset, and laboratory findings supported the diagnostic consideration. Although clinical improvement was observed following dopaminergic therapy, this finding was interpreted cautiously given potential confounding factors. This case highlights that NMS may occur without fulfilling classical diagnostic criteria and underscores the importance of integrating clinical, laboratory, and temporal features, particularly in critically ill patients.
Indexed as
Identifiers
41995787What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.